206 related articles for article (PubMed ID: 26458057)
1. CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates.
Hartmann EM; Rudelius M; Burger JA; Rosenwald A
Leuk Lymphoma; 2016; 57(3):563-71. PubMed ID: 26458057
[TBL] [Abstract][Full Text] [Related]
2. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
[TBL] [Abstract][Full Text] [Related]
4. CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia.
Popek-Marciniec S; Zmorzyński S; Koczkodaj D; Marciniec M; Wąsik-Szczepanek E; Karczmarczyk A; Michalak-Wojnowska M; Filip A
Acta Haematol; 2023; 146(4):277-286. PubMed ID: 37015191
[TBL] [Abstract][Full Text] [Related]
5. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.
Burger JA; Quiroga MP; Hartmann E; Bürkle A; Wierda WG; Keating MJ; Rosenwald A
Blood; 2009 Mar; 113(13):3050-8. PubMed ID: 19074730
[TBL] [Abstract][Full Text] [Related]
6. High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen.
Lampert IA; Wotherspoon A; Van Noorden S; Hasserjian RP
Hum Pathol; 1999 Jun; 30(6):648-54. PubMed ID: 10374772
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias.
Lad DP; Varma S; Varma N; Sachdeva MU; Bose P; Malhotra P
Leuk Lymphoma; 2015; 56(8):2424-8. PubMed ID: 25393804
[TBL] [Abstract][Full Text] [Related]
9. Lymph node histology in typical and atypical chronic lymphocytic leukemia.
Bonato M; Pittaluga S; Tierens A; Criel A; Verhoef G; Wlodarska I; Vanutysel L; Michaux L; Vandekerckhove P; Van den Berghe H; De Wolf-Peeters C
Am J Surg Pathol; 1998 Jan; 22(1):49-56. PubMed ID: 9422315
[TBL] [Abstract][Full Text] [Related]
10. EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes.
Szurián K; Csala I; Marosvári D; Rajnai H; Dezső K; Bödör C; Piurkó V; Matolcsy A; Reiniger L
Exp Mol Pathol; 2018 Oct; 105(2):161-165. PubMed ID: 30031020
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro.
Bäckman E; Bergh AC; Lagerdahl I; Rydberg B; Sundström C; Tobin G; Rosenquist R; Linderholm M; Rosén A
Haematologica; 2007 Nov; 92(11):1495-504. PubMed ID: 18024398
[TBL] [Abstract][Full Text] [Related]
12. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V
Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907
[TBL] [Abstract][Full Text] [Related]
13. A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment.
Ferretti E; Bertolotto M; Deaglio S; Tripodo C; Ribatti D; Audrito V; Blengio F; Matis S; Zupo S; Rossi D; Ottonello L; Gaidano G; Malavasi F; Pistoia V; Corcione A
Leukemia; 2011 Aug; 25(8):1268-77. PubMed ID: 21546901
[TBL] [Abstract][Full Text] [Related]
14. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
Herishanu Y; Pérez-Galán P; Liu D; Biancotto A; Pittaluga S; Vire B; Gibellini F; Njuguna N; Lee E; Stennett L; Raghavachari N; Liu P; McCoy JP; Raffeld M; Stetler-Stevenson M; Yuan C; Sherry R; Arthur DC; Maric I; White T; Marti GE; Munson P; Wilson WH; Wiestner A
Blood; 2011 Jan; 117(2):563-74. PubMed ID: 20940416
[TBL] [Abstract][Full Text] [Related]
15. CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.
Sivina M; Hartmann E; Kipps TJ; Rassenti L; Krupnik D; Lerner S; LaPushin R; Xiao L; Huang X; Werner L; Neuberg D; Kantarjian H; O'Brien S; Wierda WG; Keating MJ; Rosenwald A; Burger JA
Blood; 2011 Feb; 117(5):1662-9. PubMed ID: 21115978
[TBL] [Abstract][Full Text] [Related]
16. Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.
Cuesta-Mateos C; Brown JR; Terrón F; Muñoz-Calleja C
Front Immunol; 2021; 12():662866. PubMed ID: 33841445
[TBL] [Abstract][Full Text] [Related]
17. The relevance of cytological studies and Ki-67 reactivity to the clinical course of chronic lymphocytic leukemia.
Astsaturov IA; Samoilova RS; Iakhnina EI; Pivnik AV; Vorobiov AI
Leuk Lymphoma; 1997 Jul; 26(3-4):337-42. PubMed ID: 9322896
[TBL] [Abstract][Full Text] [Related]
18. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.
Wang M; Tan LP; Dijkstra MK; van Lom K; Robertus JL; Harms G; Blokzijl T; Kooistra K; van T'veer MB; Rosati S; Visser L; Jongen-Lavrencic M; Kluin PM; van den Berg A
J Pathol; 2008 May; 215(1):13-20. PubMed ID: 18348159
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemia.
Sachanas S; Levidou G; Angelopoulou MK; Moschogiannis M; Yiakoumis X; Kalpadakis C; Vassilakopoulos TP; Kontopidou F; Tsirkinidis P; Dimitrakopoulou A; Kokoris S; Dimitriadou E; Kyrtsonis MC; Panayiotidis P; Papadaki H; Patsouris E; Korkolopoulou P; Pangalis GA
Leuk Lymphoma; 2014 Mar; 55(3):571-82. PubMed ID: 23697878
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia.
Ahearne MJ; Willimott S; Piñon L; Kennedy DB; Miall F; Dyer MJ; Wagner SD
Br J Haematol; 2013 Aug; 162(3):360-70. PubMed ID: 23710828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]